FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 670 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC EMA Recommends Granting a Marketing Authorisation for Poherdy MOST POPULAR What to Do If You’ve Been Diagnosed With Cancer in the... June 13, 2023 Zanubrutinib’s Approval Improves Targeted Treatment for CLL January 27, 2023 New Areolar Incision Technique Leaves Almost No Scars for Breast Cancer... December 7, 2020 A radical project: video game design meets cancer research December 1, 2022 Load more HOT NEWS Foodie Friday: Butternut Squash Macaroni Casserole Καρκίνος οισοφάγου Dunkin’ Customer Surprises Homeless Employee With Fully Furnished Home Kids Facing Difficult Medical Diagnoses Take Train To The ‘North Pole’...
